FORE GENOMICS
Live / Allowed — First extension granted (statement of use) (as of 20 Apr 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Nov 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97689002
- Mark type
- Word mark
- Filed
- 22 Nov 2022
- Published for opposition
- 02 Sept 2025
- Attorney of record
- Y. Jae Kim
Goods and services
- Class 005 — Pharmaceuticals: Whole genome sequencing tests, namely, for medical, health, and diagnostic purposes, designed for healthy children, not for use in research and development services in the cancer therapy, pharmaceutical or biopharmaceutical fields.
Owner
- Fore Genomics, Inc., San Diego, CA, US
- Fore Genomics, Inc., San Diego, CA, US
Prosecution history
- 20 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Apr 2026 — SOU EXTENSION 1 GRANTED
- 20 Apr 2026 — SOU EXTENSION 1 FILED
- 20 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Sept 2025 — PUBLISHED FOR OPPOSITION
- 27 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 31 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jul 2025 — EXAMINER'S AMENDMENT ENTERED
- 31 Jul 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 31 Jul 2025 — EXAMINERS AMENDMENT E-MAILED
- 31 Jul 2025 — EXAMINERS AMENDMENT -WRITTEN
- 17 Jul 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 16 Jan 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED